Trajenta article lands Boehringer in hot water
March 19, 2012Sales and Marketing ABPI Code, PMCPA, Trajenta, breach, diabetes
Boehringer Ingelheim has been publicly reprimanded for multiple breaches of the ABPI Code of Practice. In total the manufacturer fell …
GMC guidance on off-label drug use delayed
March 19, 2012Sales and Marketing GMC, Lucentis, avastin, off label, off-label, prescribing
The General Medical Council has delayed the release of new guidance for off-label prescribing. The doctors’ regulator was expected to …
arGEN-X appoints Alain Thibault as its new chief medical officer
March 19, 2012Sales and Marketing Alain Thibault, Regeneron, arGEN-X
arGEN-X, a biopharma firm focused on the discovery and development of human monoclonal antibodies, has appointed Alain Thibault as the …
Novartis signs experimental eye drug deal
March 19, 2012Research and Development, Sales and Marketing Novartis, ThromboGenics, vitreomacular adhesion
Novartis will develop an experimental eye drug with ThromboGenics in a pact worth nearly $500 million. The deal has been …
NICE recommends Incivo for hepatitis C
March 16, 2012Sales and Marketing Incivo, Janssen, NICE, Victrelis, telaprevir
NICE is recommending Janssen’s hepatitis C pill Incivo for funding on the NHS in England. The drug has bypassed the …
Meetings, bloody meetings
March 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Meetings, clinical trials
I read recently that less than 2% of NHS Trust board meeting agenda items require decisions. What happens during the …
GSK sells off OTC products
March 16, 2012Sales and Marketing GSK, OTC, Omega Pharma, Zantac
GlaxoSmithKline has shed more of its non-core consumer health OTC products in a £391 million sale, including a German manufacturing …
NICE U-turn sees Gilenya MS pill recommended
March 16, 2012Sales and Marketing MS, NICE, UK, fingolimod, gilenya
NICE has changed its mind on Novartis’ multiple sclerosis pill Gilenya, and is now recommending the drug in a subgroup …
Updated set of mandatory Article 57(2) requirements for marketing authorisation holders
March 15, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV
An updated set of mandatory requirements for Marketing Authorisation Holders (MAH) to comply with Article 57(2) of the forthcoming new …
Four new appointments at PAN Advertising
March 15, 2012Medical Communications, Sales and Marketing Pan Advertising
PAN Advertising has made four new appointments since Jon Linscott took over as managing director in February, with two new …
GSK chooses Infosys and Fabric Worldwide for digital platform
March 15, 2012Medical Communications, Sales and Marketing Fabric Worldwide, GSK, Infosys, digital
GlaxoSmithKline has hired two technology companies to help it optimise digital communications in consumer healthcare and pharmaceuticals.The firm will work …
Photodynamic treatment for HPV shows potential
March 15, 2012Research and Development Cancer, GE Healthcare, HPV, Photocure, ipsen, oncologly
A new photodynamic therapy treatment for human papilloma virus (HPV) associated diseases of the cervix has shown potential in a …
NICE recommends Pradaxa for stroke prevention
March 15, 2012Sales and Marketing Boehringer Ingelheim, NICE, Pradaxa, atrial fibrillation
NICE has given a limited recommendation to Boehringer Ingelheim’s blood thinner Pradaxa. The watchdog said in final guidance that Pradaxa …
Dismay as Sanofi announces UK plant closure
March 15, 2012Manufacturing and Production, Sales and Marketing Plavix, Sanofi, job losses, manufacturing
Sanofi has decided to close down a manufacturing facility in the North East of the UK with the loss of …
Cmed release Global Strategic and Regulatory Consulting Booklet
March 14, 2012Research and Development
The regulatory environments within the industry continue to change and vary internationally. Cmed’s regulatory and medical professionals keep track of …
Europe’s pharma sector : living through the crisis
March 14, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma
Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …
EMA begins pilot for electronic drug applications
March 14, 2012Medical Communications EMA, European Medicines Agency, eCTD
The European Medicines Agency has launched a pilot scheme that allows pharma firms to submit new drug applications electronically. The …
Maps and apps: video interviews with healthcare professionals
March 14, 2012Medical Communications Digital Blog, apps
Last month the Department of Health released ideas for new apps aimed at patients and doctors. Below are some video …
Charity attacks Scottish decision on Zytiga
March 14, 2012Sales and Marketing Janssen, NICE, PAS, Prostate Cancer Charity, Zytiga
Scotland’s medicines regulator has turned down Janssen’s prostate cancer pill Zytiga, leading to a backlash from charities. The Scottish Medicines …
Roche’s melanoma pill launched in UK
March 14, 2012Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf
Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer. Zelboraf (vemurafenib) is the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
